IPNAF yields 2.14% · JNJ yields 2.14%● Live data
📍 IPNAF pulled ahead of the other in Year 1
Combined, IPNAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IPNAF + JNJ for your $10,000?
Information Planning CO., LTD. provides system consulting services primarily for financial institutions. It offers credit risk management related products, including comprehensive financial statement registration solution, collateral/real estate management, self-assessment/delinquency management, and risk measurement solutions. The company also provides loan related products, such as loan approval support, contract create support, benchmark aggregation, business feasibility evaluation support, and public relations support map systems; general affairs/accounting related products comprising fixed asset management, settlement business support, anti-social forces information check, investment management, expense payment office work support, and securities management systems; and tax/accounting related products, such as real-time connection and fixed asset management systems. In addition, it engages in the real estate leasing and management activities; and provision of development, planning, and system data input agency services. Information Planning CO., LTD. was incorporated in 1986 and is headquartered in Osaka, Japan.
Full IPNAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.